A tumor landscape analysis was conducted on the remaining 2539 patients who were positive for the somatic VHL variant(s), had comprehensive tumor data, and a subset of whom had been evaluated in genetics but did not have the germline VHL variants (Cohort 2; Table 1). This evidence concerns the gene VHL and neoplasm.